According to a recent LinkedIn post from Bright Uro, the company highlighted recognition of Dr. Jason Kim of Stony Brook Medicine with an Innovation Pioneer Award tied to his early adoption of the Glean Urodynamics System. The post describes Dr. Kim as an early user who has helped other clinicians implement Glean, streamline workflows, and interpret tracings, reportedly supporting broader adoption across his network.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post quotes Bright Uro CEO Derek Herrera emphasizing Dr. Kim’s role in shaping the future of the Glean platform and notes that Stony Brook now has 10 team members trained on Glean versus two on conventional urodynamics. This suggests growing clinical utilization and potential network effects, which could support higher recurring usage, strengthen clinical validation, and enhance Bright Uro’s competitive position in the urodynamics technology market.